Articles related to AGING

Unveiling the Cognitive Potential of Multivitamin Supplementation in Older Adults A recent study has unearthed new insights into the effects of multivitamin supplementation on memory performance in older adults, bringing implications for medical professionals and their approach towards cognitive health in their aging patients. Key Points: Additional Points: “We can only speculate at this time. Older adults with cardiovascular risk factors tend to have lower vitamin and mineral circulating levels. Supplementation with multivitamins may help restore these deficiencies, providing [a] secondary benefit to cognitive health.” Adam M. Brickman, PhD, Professor of Neuropsychology at Columbia University Vagelos College of Physicians and Surgeons.

Age, a Critical Moderator in Anxiety/Depression and Cognitive Outcomes in MS In recent findings from the ACTRIMS Forum 2023, researchers underscored the crucial role of age in the relationship between mental health and cognitive outcomes in patients with multiple sclerosis (MS). Key Points: “Considering age is necessary when exploring the links between depression or anxiety and cognition in people with MS.” Researchers from the University of Toronto

Dive into the potential of senolytics in combating age-related diseases, revealing how these compounds might unlock a healthier, longer life. Although senescent cells play crucial roles in early life, their persistence in later years can link to numerous age-related diseases. The potential of senolytics, such as dasatinib and quercetin (D&Q), is being explored in clearing out these harmful cells and combating age-related diseases like cancer, diabetes, and osteoporosis. To illustrate, researchers applied D&Q as senolytics in patients with idiopathic pulmonary fibrosis (IPF) and diabetic kidney disease. Findings revealed that patients showed improvements in physical function, with benefits including enhanced gait speed and increased walking distance. Similarly, the treatment significantly reduced cellular senescence in another study involving patients with diabetic kidney disease. However, caution is advised. Experts insist on the need for additional long-term studies and human clinical trials to confirm the safety of these senolytics. The majority of global morbidity, mortality, and health costs stem from chronic illnesses. Age, as indicated by JAMA, is a significant predictive factor for most of these diseases. Therefore, research aiming to “turn back the clock” and mitigate the effects of aging is well underway. Among the promising strategies is the removal of senescent cells, […]